Bluestein R H & CO LLC Amgen Inc Transaction History

Bluestein R H & CO LLC

$1.61 Billion
Q3 2022

A detailed history of Bluestein R H & CO LLC transactions in Amgen Inc stock. As of the latest transaction made, Bluestein R H & CO LLC holds 1,300 shares of AMGN stock, worth $382,888. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,300

Previous 1,300 -0.0%

Holding current value

$382,888

Previous $316,000 7.28%

% of portfolio

0.02%

Previous 0.02%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $233,580 - $259,140	-1,000 Reduced 43.48%	1,300 $317,000
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $43,276 - $51,534	200 Added 9.52%	2,300 $529,000
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $258,115 - $287,045	1,100 Added 110.0%	2,100 $534,000
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $189,210 - $243,200	1,000 New	1,000 $241,000
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $450,460 - $525,831	-2,525 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $1.43 Million - $1.62 Million	-7,734 Reduced 75.39%	2,525 $523,000
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $1.42 Million - $1.59 Million	8,550 Added 500.29%	10,259 $1.89 Million
Q1 2018 May 10, 2018	SELL	$169.43 - $198.0 $338,860 - $396,000	-2,000 Reduced 53.92%	1,709 $291,000
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $5 Million - $5.59 Million	-29,641 Reduced 88.88%	3,709 $645,000
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $5.58 Million - $6.37 Million	33,350	33,350 $6.22 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluestein R H & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluestein R H & CO LLC with notifications on news.

Account

Bluestein R H & CO LLC Amgen Inc Transaction History